Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion type Assertion NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_head.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion description "[Approximately 50% of glioblastomas (GBMs) are characterized by overexpression of the epidermal growth factor receptor (EGFR) and EGFR gene amplification.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_provenance.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion evidence source_evidence_curated NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_provenance.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion SIO_000772 19204207 NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_provenance.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion wasDerivedFrom ctd_human-20130708 NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_provenance.
- NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_assertion wasGeneratedBy ECO_0000218 NP14562.RAD9RlbssQIK_lN6cJ1l2KnYDUCsW0gmTJhhEuW-H8ZEU130_provenance.